Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial of Velcade (bortezomib) plus cyclophosphamide in newly diagnosed multiple myeloma was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with busulfan and fludarabine, with or without antithymocyte globulin, followed by d…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases [Phase 2]
Phase 2 study evaluating T-cell depletion and donor hematopoietic stem cell transplantation with T-cell infusions in patients with various h…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease [Phase 1]
Phase 1 trial of XL184 (cabozantinib) for relapsed/refractory multiple myeloma with bone disease has completed. The update indicates the stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma [Phase 2]
Phase 2 study evaluating the combination of bendamustine hydrochloride, etoposide, dexamethasone, and filgrastim for peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated pomalidomide with high-dose dexamethasone and oral cyclophosphamide in multiple myeloma; results were …
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Busulfan in Multiple Myeloma [Phase 1]
The Phase 1 clinical trial of busulfan in multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating autologous/syngeneic stem cell transplant followed by donor stem cell transplant with bortezomib in newly diagnosed…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating melphalan with peripheral stem cell transplantation followed by interleukin-2 and interferon alfa in patients wit…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients [Phase 2]
Phase 2 clinical trial evaluating carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma; study completed with pos…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT) [Phase 2]
A Phase 2 trial evaluating the combination of Velcade (bortezomib) with melphalan in autologous stem-cell transplantation for multiple myelo…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Frontline Therapy in de Novo Multiple Myeloma Patients Under 65 [Phase 2]
A Phase 2 frontline therapy study for de novo multiple myeloma patients under 65 has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Lenalidomide Maintenance Therapy for Multiple Myeloma [Phase 2]
Phase 2 clinical trial update on lenalidomide maintenance therapy for multiple myeloma; the study status is terminated with results posted i…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer [Phase 2]
Phase 2 clinical trial evaluating an anticoagulant preventive injection in patients with lymphoma or multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Diagnostic Imaging of Myeloma Bone Lesions [NA]
A completed clinical trial studying diagnostic imaging for bone lesions in multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation [Phase 1]
A Phase 1 pilot study evaluating disruption of the lymphoid tumor microenvironment prior to autologous stem cell transplantation was termina…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies [Phase 2, Phase 3]
A phase 2/3 trial evaluating non-myeloablative allogeneic HSCT from HLA-matched related or unrelated donors in low-grade B-cell malignancies…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Phase 2]
Phase 2 clinical trial evaluating the combination of plerixafor and GM-CSF (sargramostim) for mobilizing hematopoietic stem cells from allog…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating Oprozomib in combination with Melphalan and Prednisone in transplant-ineligible patients with newly diagn…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma [Phase 2]
This entry reports a Phase 2 clinical trial evaluating the combination of metformin with high-dose dexamethasone in relapsed multiple myelom…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life [Phase 2]
This document reports the results of a Phase 2 clinical trial evaluating efficacy, toxicity, harvest yield, and quality of life in patients …
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies [Phase 1]
This document reports the completion of a Phase 1 safety and pharmacology study of SNX-5422 in patients with refractory hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating lenalidomide in patients with progressive or recurrent multiple myeloma after an allogeneic stem cell tran…